Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine.
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine.
复制标题
错过的机会：药物使用热线接线员国家通过远程医疗开丁丙诺啡处方的不确定性。
DOI：
10.1097/adm.0000000000001255
复制
发表时间：
2024
影响因子：
5.5
通讯作者：
Beletsky,Leo
中科院分区：
文献类型：
--
作者：
Haley,DanielleF;Agoos,EleanorR;Yarbrough,CourtneyR;Suen,LeslieW;Beletsky,Leo
方法2021年3月至5月，我们致电美国50个州和华盛顿特区的热线电话，询问该州医生是否可以通过电话或视频会议开始或继续丁丙诺啡治疗阿片类药物使用障碍(OUD)。我们比较了运营商对丁丙诺啡远程医疗启动状态实施的反应。这项研究被波士顿大学机构审查委员会指定为非人类受试者研究。结果我们采访了47个州和华盛顿特区的运营商。记者无法联系到阿拉斯加、加利福尼亚州和蒙大拿州的运营商。大多数操作员不确定(不知道，可能是，可能不是)国家是否允许丁丙诺啡启动(81%，n=39)或继续(83%，n=40)通过远程医疗。7个州(100%)的医生可以通过远程医疗启动丁丙诺啡处方，1个州(100%)的操作员可以启动丁丙诺啡，1个州(100%)的操作员可以启动丁丙诺啡，6个州(86%)的操作员表示医生可能不能启动。然而，大多数运营商对从业者是否可以通过远程医疗启动丁丙诺啡治疗表示不确定，有时还传达了不准确的信息。迫切需要将远程医疗、特别是丁丙诺啡在OUD治疗中的作用制度化的政策任务，以及在这一不断变化的政策环境中培训和支持物质使用热线操作员的资源。
ObjectivesWe examined substance use hotline operator certainty of each US state and Washington, DC's endorsement of buprenorphine (initiation and continuation) prescribing via telemedicine.MethodsBetween March and May 2021, we called hotlines in 50 US states and Washington, DC, requesting information on whether practitioners in that state could initiate or continue buprenorphine treatment for opioid use disorder (OUD) via telephone or video conference. We compared operator responses to state implementation of buprenorphine telemedicine initiation. This study was designated as not human subjects research by the Boston University Institutional Review Board.ResultsWe spoke with operators in 47 states and Washington, DC. Operators could not be reached in Alaska, California, and Montana. Most operators were uncertain (don't know, probably yes, probably no) whether the state permitted buprenorphine initiation (81%, n= 39) or continuation (83%, n= 40) via telemedicine. Practitioners could initiate buprenorphine prescribing via telemedicine in 7 states (100%) where operators were certain practitioners could initiate buprenorphine, 1 state (100%) where the operator was certain practitioners could not, and 6 states (86%) where operators indicated practitioners probably could not.ConclusionsMost US states and Washington, DC, expanded the role of telemedicine in OUD treatment. However, most operators expressed uncertainty and sometimes communicated inaccurate information regarding whether practitioners could initiate buprenorphine treatment via telemedicine. There is an urgent need for policy mandates institutionalizing the role of telemedicine, and of buprenorphine specifically, in OUD treatment and for resources to train and support substance use hotline operators in this evolving policy environment.
登录
查看更多内容
DOI：
10.15585/mmwr.mm7034a3
发表时间：
2021-08-27
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Czeisler MÉ;Board A;Thierry JM;Czeisler CA;Rajaratnam SMW;Howard ME;Clarke KEN
通讯作者：
Clarke KEN
影响因子：
3.9
作者：
Mellis AM;Potenza MN;Hulsey JN
通讯作者：
Hulsey JN
许多临床医生实施数字股权策略来治疗阿片类药物使用障碍。
DOI：
10.1377/hlthaff.2022.00803
发表时间：
2023
期刊：
Health affairs (Project Hope)
影响因子：
--
作者：
Uscher-Pines,Lori;Riedel,LaurenE;Mehrotra,Ateev;Rose,Sherri;Busch,AlisaB;Huskamp,HaidenA
通讯作者：
Huskamp,HaidenA
影响因子：
3.7
作者：
Kitchingman, Taneile Ashlea;Caputi, Peter;Wilson, Ian
通讯作者：
Wilson, Ian
影响因子：
25.8
作者：
Santo, Thomas Jr;Clark, Brodie;Degenhardt, Louisa
通讯作者：
Degenhardt, Louisa